NickKoh
2021-08-13
👍
Hot Stocks: Analyst note drops MU; LFST, GOCO fall on earnings; DDS sets new high; XONE jumps on merger deal<blockquote>热门股票：分析师笔记下跌MU；LFST、GOCO 盈利下降；DDS创下新高；XONE 启动合并交易</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
4
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":894686786,"tweetId":"894686786","gmtCreate":1628821882345,"gmtModify":1631888955528,"author":{"id":4089548442638630,"idStr":"4089548442638630","authorId":4089548442638630,"authorIdStr":"4089548442638630","name":"NickKoh","avatar":"https://static.tigerbbs.com/801820021afe649aa2f075daeb320df1","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>👍</p></body></html>","htmlText":"<html><head></head><body><p>👍</p></body></html>","text":"👍","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/894686786","repostId":1112657019,"repostType":4,"repost":{"id":"1112657019","kind":"news","pubTimestamp":1628821759,"share":"https://www.laohunote.com/m/news/1112657019?lang=zh_CN&edition=full","pubTime":"2021-08-13 10:29","market":"us","language":"en","title":"Hot Stocks: Analyst note drops MU; LFST, GOCO fall on earnings; DDS sets new high; XONE jumps on merger deal<blockquote>热门股票：分析师笔记下跌MU；LFST、GOCO 盈利下降；DDS创下新高；XONE 启动合并交易</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1112657019","media":"Seeking Alpha","summary":"Analyst notes and earnings news spurred many of Thursday's biggest movers. M&A headlines also took a","content":"<p><ul> <li>Analyst notes and earnings news spurred many of Thursday's biggest movers. M&A headlines also took a share of the spotlight, sparking one of the day's biggest gains.</li> <li>On the analyst front, a Morgan Stanley downgrade prompted a sharp decline in Micron. The selling also impacted other players in the sector, with <a href=\"https://laohu8.com/S/LRCX\">Lam Research</a>, <a href=\"https://laohu8.com/S/KLAC\">KLA-Tencor</a> and <a href=\"https://laohu8.com/S/AMAT\">Applied Materials</a> all taking a step down during the session.</li> <li>The release of financial figures inspired a massive decline in LifeStance Health. A wider-than-expected loss and weak guidance turned this into one of the day's biggest decliners.</li> <li>GoHealth also endured a substantial sell-off following its quarterly report. The stock plunged to a new 52-week low as a weak bottom-line figure took Wall Street by surprise.</li> <li>Earnings news also had its winners on Thursday. This list included Dillard's, which overcame turbulent intraday trading to set a fresh 52-week high.</li> <li>Meanwhile, ExOne scored a place among the day's biggest gainers. The stock skyrocketed following the announcement of a merger deal.</li> </ul> <h3><b>Sector In Focus</b></h3> <ul> <li><a href=\"https://laohu8.com/S/MS\">Morgan Stanley</a> lowered its rating on <a href=\"https://laohu8.com/S/MU\">Micron Technology</a> on Thursday, warning that \"winter is coming\" for the sector. Specifically, the analyst said its cycle indicators pointed to late-cycle business -- a tough time for companies like Micron and the first time this has happened since 2019.</li> <li>As a result, Morgan Stanley downgraded MU to Equal-Weight from Overweight. It also cut its price target to $75 from the previous level of $105.</li> <li>MU dropped nearly 5% on the session to finish at $70.25. This represented its lowest close since December.</li> <li>The slide spilled over to the rest of the semiconductor equipment space. LRCX, AMAT and KLAC all declined more than 4% on the session.</li> </ul> <h3><b>Standout Gainer</b></h3> <ul> <li>Late Wednesday, industrial 3D printing firm <a href=\"https://laohu8.com/S/XONE\">ExOne</a> announced a definitive agreement to be acquired by <a href=\"https://laohu8.com/S/DM\">Desktop Metal Inc.</a>. Under the deal, each XONE share will be exchanged for $8.50 in cash and $17 in DM stock.</li> <li>The total consideration of $25.50 per share represents an overall value of $575M.</li> <li>XONE jumped 45% on the session to finish at $25.08. However, this was well off a 52-week high reached in February, when it touched a peak of $66.48.</li> <li>XONE had a brief career as a high flier early this year. The stock rallied from under $10 on the last day of 2020 to reach its peak above $66 within the next six weeks of 2021.</li> <li>The stock came off those levels through February and has generally moved sideways in recent months. Even with Thursday's colossal advance, shares remain down 49% over the last six months.</li> </ul> <h3><b>Standout Loser</b></h3> <ul> <li><a href=\"https://laohu8.com/S/LFST\">LifeStance Health Group, Inc.</a> posted a Q2 per-share loss that was double the amount that analysts had predicted. The weak bottom line came despite revenue that topped projections, rising 91% to $160.5M.</li> <li>The mental healthcare company also issued a disappointing forecast for Q3. The firm projected a top-line figure between $168M and $173M for the quarter, below the $175.7M predicted by analysts.</li> <li>Dragged down by the earnings news, LFST plunged more than 46% to close at $11.71.</li> <li>LFST came public in mid-June with an IPO priced at $18. In the month following its public debut, the stock reached as high as $29.81.</li> <li>However, shares fell in the second half of July and have generally moved sideways in the weeks headed into its earnings report.</li> <li>With Thursday's plunge, LFST is 35% below its IPO price and 61% lower than its all-time high.</li> </ul> <h3><b>Notable New High</b></h3> <ul> <li><a href=\"https://laohu8.com/S/DDS\">Dillard's</a> had a bumpy ride after its latest earnings report.</li> <li>The stock initially spiked at the open on Thursday, but quickly reversed course and dropped into negative territory. Buyers stepped in at that point, sending shares back above the flat line and almost to their initial intraday peak.</li> <li>The choppy trading was inspired by the department store chain's quarterly update. The company reported a Q2 profit compared to a loss in the same period last year. Revenue topped projections, rising 71% from last year to $1.57B.</li> <li>A strong showing in ladies' apparel and shoes underpinned the sales recovery. The company also benefited from better margins, which expanded to 41% compared to just over 30% a year ago.</li> <li>Despite its choppy start, DDS finished Thursday's trading at $191.48, an advanc</p><p><blockquote><ul><li>分析师报告和盈利消息刺激了周四许多最大的走势。并购头条新闻也成为焦点，引发了当天最大的涨幅之一。</li><li>在分析师方面，摩根士丹利下调评级导致美光股价大幅下跌。此次出售还影响了该行业的其他参与者，<a href=\"https://laohu8.com/S/LRCX\">林研究</a>,<a href=\"https://laohu8.com/S/KLAC\">克拉-滕科尔</a>和<a href=\"https://laohu8.com/S/AMAT\">应用材料</a>所有人都在会议期间退一步。</li><li>财务数据的公布导致生活健康状况大幅下降。超出预期的跌幅和疲软的指引使其成为当天最大的跌幅之一。</li><li>GoHealth 在发布季度报告后也遭遇了大幅抛售。由于疲软的底线数据令华尔街感到意外，该股暴跌至 52 周新低。</li><li>周四的盈利新闻也有赢家。这份名单包括迪拉德的股票，该公司克服了动荡的盘中交易，创下了 52 周新高。</li><li>与此同时，ExOne 成为当天涨幅最大的股票之一。合并交易宣布后，该股飙升。</li></ul><h3><b>重点领域</b></h3><ul><li><a href=\"https://laohu8.com/S/MS\">摩根士丹利</a>下调评级<a href=\"https://laohu8.com/S/MU\">美光科技</a>周四，警告该行业“冬天即将来临”。具体来说，该分析师表示，其周期指标指向周期后期业务——对于美光等公司来说，这是一个艰难的时期，也是自 2019 年以来首次发生这种情况。</li><li>因此，摩根士丹利将 MU 的评级从跑赢大盘下调至同等权重。它还将目标价从之前的 105 美元下调至 75 美元。</li><li>MU 盘中下跌近 5%，收于 70.25 美元。这是自 12 月以来的最低收盘价。</li><li>滑坡蔓延到半导体设备领域的其余部分。LRCX、AMAT 和 KLAC 盘中均下跌超过 4%。</li></ul><h3><b>突出收益者</b></h3><ul><li>周三晚间，工业 3D 打印公司<a href=\"https://laohu8.com/S/XONE\">外显子</a>宣布最终协议将由<a href=\"https://laohu8.com/S/DM\">桌面金属公司。</a>根据交易，每股XONE股票将兑换8.50美元现金和17美元DM股票。</li><li>每股 25.50 美元的总代价，总价值为 5.75 亿美元。</li><li>XONE 盘中上涨 45%，收于 25.08 美元。然而，这远远低于 2 月份触及 66.48 美元的峰值的 52 周高点。</li><li>今年早些时候，XONE有过短暂的雄心勃勃的职业生涯。该股从 2020 年最后一天的 10 美元以下反弹，并在 2021 年接下来的六周内达到 66 美元以上的峰值。</li><li>该股在二月份脱离了这些水平，近几个月来普遍横盘整理。尽管周四股价大幅上涨，但过去六个月股价仍下跌了 49%。</li></ul><h3><b>杰出的失败者</b></h3><ul><li><a href=\"https://laohu8.com/S/LFST\">生活舞蹈健康集团公司。</a>第二季度每股亏损是分析师预测的两倍。尽管收入超出预期，增长 91% 至 1.605 亿美元，但利润仍然疲软。</li><li>这家精神医疗保健公司还发布了令人失望的第三季度预测。该公司预计本季度营收在 1.68 亿美元至 1.73 亿美元之间，低于分析师预测的 1.757 亿美元。</li><li>受财报消息拖累，LFST 暴跌超过 46%，收于 11.71 美元。</li><li>LFST 于 6 月中旬上市，IPO 定价为 18 美元。在首次公开亮相后的一个月内，该股最高达到 29.81 美元。</li><li>然而，股价在 7 月下半月下跌，并且在财报发布前几周普遍横盘整理。</li><li>随着周四的暴跌，LFST 比其 IPO 价格低 35%，比历史高点低 61%。</li></ul><h3><b>显著新高</b></h3><ul><li><a href=\"https://laohu8.com/S/DDS\">迪拉德的</a>最新财报发布后，经历了一段坎坷的旅程。</li><li>该股周四开盘时最初飙升，但很快逆转并跌入负值区域。此时买家介入，将股价推回平线上方，几乎达到最初的盘中峰值。</li><li>波动的交易受到该百货连锁店季度更新的启发。该公司公布第二季度利润，而去年同期则亏损。收入超出预期，较去年增长 71%，达到 $1.57B。</li><li>女装和鞋类的强劲表现支撑了销售复苏。该公司还受益于更好的利润率，从一年前的 30% 多一点扩大到 41%。</li><li>尽管开局起伏不定，但 DDS 周四收盘价为 191.48 美元，上涨</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hot Stocks: Analyst note drops MU; LFST, GOCO fall on earnings; DDS sets new high; XONE jumps on merger deal<blockquote>热门股票：分析师笔记下跌MU；LFST、GOCO 盈利下降；DDS创下新高；XONE 启动合并交易</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHot Stocks: Analyst note drops MU; LFST, GOCO fall on earnings; DDS sets new high; XONE jumps on merger deal<blockquote>热门股票：分析师笔记下跌MU；LFST、GOCO 盈利下降；DDS创下新高；XONE 启动合并交易</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-08-13 10:29</span>\n</p>\n</h4>\n</header>\n<article>\n<p><ul> <li>Analyst notes and earnings news spurred many of Thursday's biggest movers. M&A headlines also took a share of the spotlight, sparking one of the day's biggest gains.</li> <li>On the analyst front, a Morgan Stanley downgrade prompted a sharp decline in Micron. The selling also impacted other players in the sector, with <a href=\"https://laohu8.com/S/LRCX\">Lam Research</a>, <a href=\"https://laohu8.com/S/KLAC\">KLA-Tencor</a> and <a href=\"https://laohu8.com/S/AMAT\">Applied Materials</a> all taking a step down during the session.</li> <li>The release of financial figures inspired a massive decline in LifeStance Health. A wider-than-expected loss and weak guidance turned this into one of the day's biggest decliners.</li> <li>GoHealth also endured a substantial sell-off following its quarterly report. The stock plunged to a new 52-week low as a weak bottom-line figure took Wall Street by surprise.</li> <li>Earnings news also had its winners on Thursday. This list included Dillard's, which overcame turbulent intraday trading to set a fresh 52-week high.</li> <li>Meanwhile, ExOne scored a place among the day's biggest gainers. The stock skyrocketed following the announcement of a merger deal.</li> </ul> <h3><b>Sector In Focus</b></h3> <ul> <li><a href=\"https://laohu8.com/S/MS\">Morgan Stanley</a> lowered its rating on <a href=\"https://laohu8.com/S/MU\">Micron Technology</a> on Thursday, warning that \"winter is coming\" for the sector. Specifically, the analyst said its cycle indicators pointed to late-cycle business -- a tough time for companies like Micron and the first time this has happened since 2019.</li> <li>As a result, Morgan Stanley downgraded MU to Equal-Weight from Overweight. It also cut its price target to $75 from the previous level of $105.</li> <li>MU dropped nearly 5% on the session to finish at $70.25. This represented its lowest close since December.</li> <li>The slide spilled over to the rest of the semiconductor equipment space. LRCX, AMAT and KLAC all declined more than 4% on the session.</li> </ul> <h3><b>Standout Gainer</b></h3> <ul> <li>Late Wednesday, industrial 3D printing firm <a href=\"https://laohu8.com/S/XONE\">ExOne</a> announced a definitive agreement to be acquired by <a href=\"https://laohu8.com/S/DM\">Desktop Metal Inc.</a>. Under the deal, each XONE share will be exchanged for $8.50 in cash and $17 in DM stock.</li> <li>The total consideration of $25.50 per share represents an overall value of $575M.</li> <li>XONE jumped 45% on the session to finish at $25.08. However, this was well off a 52-week high reached in February, when it touched a peak of $66.48.</li> <li>XONE had a brief career as a high flier early this year. The stock rallied from under $10 on the last day of 2020 to reach its peak above $66 within the next six weeks of 2021.</li> <li>The stock came off those levels through February and has generally moved sideways in recent months. Even with Thursday's colossal advance, shares remain down 49% over the last six months.</li> </ul> <h3><b>Standout Loser</b></h3> <ul> <li><a href=\"https://laohu8.com/S/LFST\">LifeStance Health Group, Inc.</a> posted a Q2 per-share loss that was double the amount that analysts had predicted. The weak bottom line came despite revenue that topped projections, rising 91% to $160.5M.</li> <li>The mental healthcare company also issued a disappointing forecast for Q3. The firm projected a top-line figure between $168M and $173M for the quarter, below the $175.7M predicted by analysts.</li> <li>Dragged down by the earnings news, LFST plunged more than 46% to close at $11.71.</li> <li>LFST came public in mid-June with an IPO priced at $18. In the month following its public debut, the stock reached as high as $29.81.</li> <li>However, shares fell in the second half of July and have generally moved sideways in the weeks headed into its earnings report.</li> <li>With Thursday's plunge, LFST is 35% below its IPO price and 61% lower than its all-time high.</li> </ul> <h3><b>Notable New High</b></h3> <ul> <li><a href=\"https://laohu8.com/S/DDS\">Dillard's</a> had a bumpy ride after its latest earnings report.</li> <li>The stock initially spiked at the open on Thursday, but quickly reversed course and dropped into negative territory. Buyers stepped in at that point, sending shares back above the flat line and almost to their initial intraday peak.</li> <li>The choppy trading was inspired by the department store chain's quarterly update. The company reported a Q2 profit compared to a loss in the same period last year. Revenue topped projections, rising 71% from last year to $1.57B.</li> <li>A strong showing in ladies' apparel and shoes underpinned the sales recovery. The company also benefited from better margins, which expanded to 41% compared to just over 30% a year ago.</li> <li>Despite its choppy start, DDS finished Thursday's trading at $191.48, an advanc</p><p><blockquote><ul><li>分析师报告和盈利消息刺激了周四许多最大的走势。并购头条新闻也成为焦点，引发了当天最大的涨幅之一。</li><li>在分析师方面，摩根士丹利下调评级导致美光股价大幅下跌。此次出售还影响了该行业的其他参与者，<a href=\"https://laohu8.com/S/LRCX\">林研究</a>,<a href=\"https://laohu8.com/S/KLAC\">克拉-滕科尔</a>和<a href=\"https://laohu8.com/S/AMAT\">应用材料</a>所有人都在会议期间退一步。</li><li>财务数据的公布导致生活健康状况大幅下降。超出预期的跌幅和疲软的指引使其成为当天最大的跌幅之一。</li><li>GoHealth 在发布季度报告后也遭遇了大幅抛售。由于疲软的底线数据令华尔街感到意外，该股暴跌至 52 周新低。</li><li>周四的盈利新闻也有赢家。这份名单包括迪拉德的股票，该公司克服了动荡的盘中交易，创下了 52 周新高。</li><li>与此同时，ExOne 成为当天涨幅最大的股票之一。合并交易宣布后，该股飙升。</li></ul><h3><b>重点领域</b></h3><ul><li><a href=\"https://laohu8.com/S/MS\">摩根士丹利</a>下调评级<a href=\"https://laohu8.com/S/MU\">美光科技</a>周四，警告该行业“冬天即将来临”。具体来说，该分析师表示，其周期指标指向周期后期业务——对于美光等公司来说，这是一个艰难的时期，也是自 2019 年以来首次发生这种情况。</li><li>因此，摩根士丹利将 MU 的评级从跑赢大盘下调至同等权重。它还将目标价从之前的 105 美元下调至 75 美元。</li><li>MU 盘中下跌近 5%，收于 70.25 美元。这是自 12 月以来的最低收盘价。</li><li>滑坡蔓延到半导体设备领域的其余部分。LRCX、AMAT 和 KLAC 盘中均下跌超过 4%。</li></ul><h3><b>突出收益者</b></h3><ul><li>周三晚间，工业 3D 打印公司<a href=\"https://laohu8.com/S/XONE\">外显子</a>宣布最终协议将由<a href=\"https://laohu8.com/S/DM\">桌面金属公司。</a>根据交易，每股XONE股票将兑换8.50美元现金和17美元DM股票。</li><li>每股 25.50 美元的总代价，总价值为 5.75 亿美元。</li><li>XONE 盘中上涨 45%，收于 25.08 美元。然而，这远远低于 2 月份触及 66.48 美元的峰值的 52 周高点。</li><li>今年早些时候，XONE有过短暂的雄心勃勃的职业生涯。该股从 2020 年最后一天的 10 美元以下反弹，并在 2021 年接下来的六周内达到 66 美元以上的峰值。</li><li>该股在二月份脱离了这些水平，近几个月来普遍横盘整理。尽管周四股价大幅上涨，但过去六个月股价仍下跌了 49%。</li></ul><h3><b>杰出的失败者</b></h3><ul><li><a href=\"https://laohu8.com/S/LFST\">生活舞蹈健康集团公司。</a>第二季度每股亏损是分析师预测的两倍。尽管收入超出预期，增长 91% 至 1.605 亿美元，但利润仍然疲软。</li><li>这家精神医疗保健公司还发布了令人失望的第三季度预测。该公司预计本季度营收在 1.68 亿美元至 1.73 亿美元之间，低于分析师预测的 1.757 亿美元。</li><li>受财报消息拖累，LFST 暴跌超过 46%，收于 11.71 美元。</li><li>LFST 于 6 月中旬上市，IPO 定价为 18 美元。在首次公开亮相后的一个月内，该股最高达到 29.81 美元。</li><li>然而，股价在 7 月下半月下跌，并且在财报发布前几周普遍横盘整理。</li><li>随着周四的暴跌，LFST 比其 IPO 价格低 35%，比历史高点低 61%。</li></ul><h3><b>显著新高</b></h3><ul><li><a href=\"https://laohu8.com/S/DDS\">迪拉德的</a>最新财报发布后，经历了一段坎坷的旅程。</li><li>该股周四开盘时最初飙升，但很快逆转并跌入负值区域。此时买家介入，将股价推回平线上方，几乎达到最初的盘中峰值。</li><li>波动的交易受到该百货连锁店季度更新的启发。该公司公布第二季度利润，而去年同期则亏损。收入超出预期，较去年增长 71%，达到 $1.57B。</li><li>女装和鞋类的强劲表现支撑了销售复苏。该公司还受益于更好的利润率，从一年前的 30% 多一点扩大到 41%。</li><li>尽管开局起伏不定，但 DDS 周四收盘价为 191.48 美元，上涨</li></ul></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3730037-hot-stocks-analyst-note-drops-mu-lfst-goco-fall-on-earnings-dds-sets-new-high-xone-jumps-on-merger-deal\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOCO":"GoHealth","LFST":"LifeStance Health Group, Inc.","MU":"美光科技","DDS":"狄乐百货","XONE":"BondBloxx Bloomberg One Year Target Duration US Treasury ETF"},"source_url":"https://seekingalpha.com/news/3730037-hot-stocks-analyst-note-drops-mu-lfst-goco-fall-on-earnings-dds-sets-new-high-xone-jumps-on-merger-deal","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112657019","content_text":"Analyst notes and earnings news spurred many of Thursday's biggest movers. M&A headlines also took a share of the spotlight, sparking one of the day's biggest gains.\nOn the analyst front, a Morgan Stanley downgrade prompted a sharp decline in Micron. The selling also impacted other players in the sector, with Lam Research, KLA-Tencor and Applied Materials all taking a step down during the session.\nThe release of financial figures inspired a massive decline in LifeStance Health. A wider-than-expected loss and weak guidance turned this into one of the day's biggest decliners.\nGoHealth also endured a substantial sell-off following its quarterly report. The stock plunged to a new 52-week low as a weak bottom-line figure took Wall Street by surprise.\nEarnings news also had its winners on Thursday. This list included Dillard's, which overcame turbulent intraday trading to set a fresh 52-week high.\nMeanwhile, ExOne scored a place among the day's biggest gainers. The stock skyrocketed following the announcement of a merger deal.\n\nSector In Focus\n\nMorgan Stanley lowered its rating on Micron Technology on Thursday, warning that \"winter is coming\" for the sector. Specifically, the analyst said its cycle indicators pointed to late-cycle business -- a tough time for companies like Micron and the first time this has happened since 2019.\nAs a result, Morgan Stanley downgraded MU to Equal-Weight from Overweight. It also cut its price target to $75 from the previous level of $105.\nMU dropped nearly 5% on the session to finish at $70.25. This represented its lowest close since December.\nThe slide spilled over to the rest of the semiconductor equipment space. LRCX, AMAT and KLAC all declined more than 4% on the session.\n\nStandout Gainer\n\nLate Wednesday, industrial 3D printing firm ExOne announced a definitive agreement to be acquired by Desktop Metal Inc.. Under the deal, each XONE share will be exchanged for $8.50 in cash and $17 in DM stock.\nThe total consideration of $25.50 per share represents an overall value of $575M.\nXONE jumped 45% on the session to finish at $25.08. However, this was well off a 52-week high reached in February, when it touched a peak of $66.48.\nXONE had a brief career as a high flier early this year. The stock rallied from under $10 on the last day of 2020 to reach its peak above $66 within the next six weeks of 2021.\nThe stock came off those levels through February and has generally moved sideways in recent months. Even with Thursday's colossal advance, shares remain down 49% over the last six months.\n\nStandout Loser\n\nLifeStance Health Group, Inc. posted a Q2 per-share loss that was double the amount that analysts had predicted. The weak bottom line came despite revenue that topped projections, rising 91% to $160.5M.\nThe mental healthcare company also issued a disappointing forecast for Q3. The firm projected a top-line figure between $168M and $173M for the quarter, below the $175.7M predicted by analysts.\nDragged down by the earnings news, LFST plunged more than 46% to close at $11.71.\nLFST came public in mid-June with an IPO priced at $18. In the month following its public debut, the stock reached as high as $29.81.\nHowever, shares fell in the second half of July and have generally moved sideways in the weeks headed into its earnings report.\nWith Thursday's plunge, LFST is 35% below its IPO price and 61% lower than its all-time high.\n\nNotable New High\n\nDillard's had a bumpy ride after its latest earnings report.\nThe stock initially spiked at the open on Thursday, but quickly reversed course and dropped into negative territory. Buyers stepped in at that point, sending shares back above the flat line and almost to their initial intraday peak.\nThe choppy trading was inspired by the department store chain's quarterly update. The company reported a Q2 profit compared to a loss in the same period last year. Revenue topped projections, rising 71% from last year to $1.57B.\nA strong showing in ladies' apparel and shoes underpinned the sales recovery. The company also benefited from better margins, which expanded to 41% compared to just over 30% a year ago.\nDespite its choppy start, DDS finished Thursday's trading at $191.48, an advance of about 5% on the session. During the day, the stock set a 52-week high of $196.16.\n\nNotable New Low\n\nShares of GoHealth fell off a cliff on Thursday, reaching their lowest level since last year's IPO. The decline followed the release of a disappointing earnings report.\nThe marketplace for Medicare plans reported a loss for the quarter that was more than 70% wider than analysts had predicted. Meanwhile, the firm's revenue managed to exceed projections, climbing 55% to nearly $197M.\nThe weak report inspired a series of downgrades from Wall Street analysts. Raymond James and Credit Suisse were among the firms that lowered their ratings on GOCO.\nThe negative reaction to GOCO's earnings sent the stock lower by 43% on Thursday. It closed at $4.69 after touching a 52-week low of $4.61.\nGOCO came public in July 2020 in an IPO priced at $21. The stock began declining almost immediately. Since its public debut more than a year ago, shares have only closed above their IPO price three times.\nTo track the day's biggest movers throughout the session, turn to SA's On The Move section.","news_type":1,"symbols_score_info":{"DM":0.9,"LFST":0.9,"DDS":0.9,"XONE":0.9,"GOCO":0.9,"MU":0.9}},"isVote":1,"tweetType":1,"viewCount":1090,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/894686786"}
精彩评论